Get Premium to unlock powerful stock data

Insiders Roundup: NGM, Legg Mason

Largest insider trades of the week

Author's Avatar
Tiziano Frateschi
Apr 03, 2020
Article's Main Image

The GuruFocus All-in-One Screener can be used to find insider trades from a specific period of time or for a certain range of values. For these stock picks, I went under the Insiders tab and changed the settings for All Insider Buying to “$5,000,000+,” the duration to “April 2020” and All Insider Sales to “$5,000,000+.”

According to these filters, the following are this past week's most significant trades from company insiders.

NGM Biopharmaceuticals

Directors and 10% owners Peter Svennilson and David V. Goeddel and 10% owner Column Group LP bought a combined 1 million shares of NGM Biopharmaceuticals Inc. (NGM) for an average price of $12.40 per share on April 2.

0ac30628cf5c9bd7f33d7738c7689c27.png

The biopharmaceutical company has a market cap of $865 million and an enterprise value of $521 million. It has institutional ownership of 6.29% and insider ownership of 1.54%.

Over the past 12 months, the stock has declined 8.5%. As of Friday, it was trading 26.15% below its three-month high and 46.19% above its three-month low.

Shell Midstream Partners

10% owner Shell Pipeline Co. LP bought 180 million shares of Shell Midstream Partners LP (SHLX) for an average price of $1.66 per share on April 1.

2e771679bb162c7b9621839f6d9545bf.png

The operator of oil and gas midstream assets has a market cap of $2.42 billion and an enterprise value of $4.88 billion. It has institutional ownership of 26.35% and insider ownership of 0.05%.

Over the past 12 months, the stock has declined 53%. As of Friday, it was trading 55.77% below its 52-week high and 76.14% above its 52-week low.

Evans & Sutherland Computer

Stephen T. Winn, 10% owner of Evans & Sutherland Computer Corp. (ESCC), bought 21,067 shares for an average price of $1.19 per share on March 31.

130b2fbf9cbc136a84124b13642e74c0.png

The consumer electronic company has a market cap of $13.38 million and an enterprise value of $11.22 million. It has institutional ownership of 1.53% and insider ownership of 3.27%.

Over the past 12 months, the stock has increased 56%. As of Friday, it was trading 3.72% below its 52-week high and 117.76% above its 52-week low.

AVX

Kyocera Corp., 10% owner of AVX Corp. (AVX), bought 31 million shares for an average price of $21.75 per share on March 30.

ffefdd6b1f172aa595ef8bface4890b0.png

The manufacturer of electronic components has a market cap of $3.67 billion and an enterprise value of $2.91 billion. It has institutional ownership of 20.13% and insider ownership of 0.24%.

Over the past 12 months, the shares have increased 18%. As of Friday, the stock was trading 1.05% below its 52-week high and 66.23% above its 52-week low.

FactSet Research Systems

CEO Philip Frederick Snow and Director A. Philip Hadley sold 54,333 shares of FactSet Research Systems Inc. (FDS) for an average price of $252.84 per share on April 1.

c53aa25ad9af09a7756488fe9ec247fa.png

The provider of financial data has a market cap of $9.83 billion and enterprise value of $10.32 billion. It has institutional ownership of 65.36% and insider ownership of 17.64%.

Over the past 12 months, the stock increased 2.23%. As of Friday, it was trading 16.49% below its 52-week high and 32.72% above its 52-week low.

Legg Mason

Executive Vice President Terence Johnson and Chairman, President and CEO Joseph A. Sullivan sold a combined 201,171 shares of Legg Mason Inc. (LM) for an average price of $48.77 per share on March 31.

0d791669bdb4b4adeea815463d792963.png

The provider of investment management services has a market cap of $4.27 billion and an enterprise value of $5.29 billion. It has insider ownership of 8.54% and institutional ownership of 45.75%.

Over the past 12 months, the stock has gained 70.82%. As of Friday, shares were trading 3.23% below the 52-week high and 70.88% above the 52-week low.

Guardant Health

Guardant Health Inc. (GH) CEO Helmy Eltoukhy sold 281,196 shares for an average price of $70.16 per share on March 31.

47a5726caaedda5c1f388b9459446aa0.png

The precision oncology company has a market cap of $6.10 billion and enterprise value of $5.62 billion. It has insider ownership of 4.22% and institutional ownership of 35.72%.

Over the past 12 months, the stock has declined 8.14%. As of Friday, shares were trading 42.68% below the 52-week high and 15.06% above the 52-week low.

Disclosure: I do not own any stocks mentioned.

Read more here:

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
Rating:
0 / 5 (0 votes)

Please Login to leave a comment